homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

August 9, 2018

Omeros

In Seattle, biopharmaceutical company Omeros named Dr. Eckhard Leifke chief medical officer and vice president of clinical development. Leifke has more than 20 years of drug development experience, having built and headed global teams at Sanofi, Bayer and Takeda. He takes over for Dr. J. Steven Whitaker, who is focusing on regulatory approvals for Omeros' antibody drug OMS721.




Email or user name:
Password:
 
Forgot password? Click here.